DARIO RUSCIANO

Dr. DARIO RUSCIANO

Ofta Research and Development, Fidia Farmaceutici (Italy), Abano Terme, Italy
orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2004 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
ARAndrea Sudano Roccaro
Andrea Sudano Roccaro
ABAnna Rita Blanco
Anna Rita Blanco
FGFrancesco Giuliano
Francesco Giuliano
DARIO RUSCIANODARIO RUSCIANO
DARIO RUSCIANO
VEVincenzo Enea
Vincenzo Enea
Epigallocatechin-gallate (EGCg), the major catechin present in green tea extracts, has been shown to have several antibacterial activities, limiting bacterial growth and invasion and acting in synergy with β-lactam antibiotics. In this article, we report that EGCg at doses half and below its calculated MIC of 100 μg/ml, is able to reverse tetracycline resistance in staphylococcal isolates expressing the specific efflux pump Tet(K) and appears to improve the MICs of tetracycline for susceptible staphylococcal isolates as well. The visible effect of EGCg is an increased accumulation of tetracycline inside bacterial cells. This effect is likely due to the inhibition of pump activity, and it is evident not only for Tet(K) pumps but also for efflux pumps of a different class [Tet(B)]. In summary, our data indicate that the observed dramatic enhancement by EGCg of tetracycline activity for resistant staphylococcal isolates is caused by impairment of tetracycline efflux pump activity and increased intracellular retention of the drug, suggesting a possible use of EGCg as an adjuvant in antibacterial therapy.

31 October 2016 in Current Neuropharmacology
Verified
Journal Article
Open access
Michelino Di RosaMichelino Di Rosa
Michelino Di Rosa
GDGisella Distefano
Gisella Distefano
Caterina GaglianoCaterina Gagliano
Caterina Gagliano
DARIO RUSCIANODARIO RUSCIANO
DARIO RUSCIANO
LMLucia Malaguarnera
Lucia Malaguarnera
Autophagy is an important homeostatic cellular process encompassing a number of consecutive steps indispensable for degrading and recycling cytoplasmic materials. Basically autophagy is an adaptive response that under stressful conditions guarantees the physiological turnover of senescent and impaired organelles and, thus, controls cell fate by various cross-talk signals. Diabetic retinopathy (DR) is a serious microvascular complication of diabetes and accounts for 5% of all blindness. Although, various metabolic disorders have been linked with the onset of DR, due to the complex character of this multi-factorial disease, a connection between any particular defect and DR becomes speculative. Diabetes increases inflammation, advanced glycation end products (AGEs) and oxidative stress in the retina and its capillary cells. Particularly, a great number of evidence suggests a mutual connection between oxidative stress and other major metabolic abnormalities implicated in the development of DR. In addition, the intricate networks between autophagy and apoptosis establish the degree of cellular apoptosis and the progression of DR. Growing data underline the crucial role of reactive oxygen species (ROS) in the activation of autophagy. Depending on their delicate balance both redox signaling and autophagy, being detrimental or beneficial, retain opposing effects. The molecular mechanisms of autophagy are very complex and involve many signalling pathways cooperating at various steps. This review summarizes recent advances of the possible molecular mechanisms in autophagic process that are involved pathophysiology of DR. In-depth analysis on the molecular mechanisms leading to autophagy in the retinal pigment epithelial (RPE) will be helpful to plan new therapies aimed at preventing or improving the progression of DR.

1 October 2005 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
ABAnna Rita Blanco
Anna Rita Blanco
ASAndrea Sudano-Roccaro
Andrea Sudano-Roccaro
GSGiovanna Carmela Spoto
Giovanna Carmela Spoto
ANAntonia Nostro
Antonia Nostro
DARIO RUSCIANODARIO RUSCIANO
DARIO RUSCIANO
Epigallocatechin gallate (EGCg), the main polyphenol component of green tea, has several antibacterial properties. Here we show that sub-MICs of EGCg appear to decrease slime production, therefore inhibiting biofilm formation by ocular staphylococcal isolates previously characterized for the presence of ica genes by the Congo red agar plate assay and for adhesion to microtiter plates.

1 July 2007 in Brain Research
Verified
Journal Article
Closed access
BZBo Zhang
Bo Zhang
RSRukhsana Safa
Rukhsana Safa
DARIO RUSCIANODARIO RUSCIANO
DARIO RUSCIANO
NONeville N. Osborne
Neville N. Osborne

1 March 2008 in Brain Research
Verified
Journal Article
Closed access
BZBo Zhang
Bo Zhang
DARIO RUSCIANODARIO RUSCIANO
DARIO RUSCIANO
NONeville N. Osborne
Neville N. Osborne

20 January 2015 in Ophthalmic and Physiological Optics
Verified
Journal Article
Closed access
PDF file
NPNicola Pescosolido
Nicola Pescosolido
VGVittorio Gatto
Vittorio Gatto
ASAlessio Stefanucci
Alessio Stefanucci
DARIO RUSCIANODARIO RUSCIANO
DARIO RUSCIANO